KEAP1 mutations—which often co-occur with STK11 in smoking-related lung cancers—are also enriched in KRAS-mutant NSCLC, found in roughly 10–20% of KRAS G12C tumors, defining a distinct subset [17,18]. This evidence concerns the gene KRAS and lung carcinoma.